Chinese porcine joint venture received regulatory approval, triggering final $7.5M milestone payment from BCA to Genus.

British animal genetics company Genus expects to report full-year adjusted pretax profit "moderately above" the upper end of current market expectations, sending its shares as much as 15.3% higher on ...

Last September, Basingstoke-based Genus struck a deal to accelerate its 49%-owned porcine joint venture with BCA in China.

Following this strong performance, Genus now anticipates its full-year 2026 adjusted profit before tax to be moderately above the top end of current market expectations, which range from £82.7 million ...

Berenberg has raised its target price for Genus following the animal genetics group's first-half trading update on Friday, keeping the stock at a 'buy' citing "multiple catalysts" for the year ahead.

The Basingstoke, England-based animal biotechnology and genetics company said adjusted pretax profit for the six months to December 31 will be about GBP50 million, ahead of expectations. It will be ...